MelaFind® (Melanoma Detection)

MelaFind JPEG.jpg

The MelaFind® melanoma detection system was developed by Mela Sciences a clinical dermatology company.1  The system is used to help evaluate suspicious skin abnormalities (lesions).  Specifically, the test is used to determine whether a particular colored (pigmented) skin lesion is likely to be melanoma.  MelaFind® uses a sophisticated imaging system to capture photographs of the skin abnormality.  The photograph is then compared to a database created from 10,000 skin biopsies.  The result is a simple 'yes' or 'no'.  The result can be used to help guide biopsy decisions.  In clinical trials, MelaFind® was found to be very sensitive in detecting melanoma.2  The test was approved by the FDA in November 2011.3

MelaFind® is not used on all skin lesions or all part of the body.  According to the manufacturer's website, MelaFind® is effective at finding melanomas ranging in size from 0.2 cm to 2.2 cm (2.54 cm = 1 inch).  Larger or smaller lesions are not readily imaged by the system's cameras.

For more information about melanoma diagnosis and staging visit the Winship Cancer Institute of Emory University.